Newsroom

Categories: Microscopy & Imaging, Clinical Diagnostics

The Institute of Tissue Medicine of the University of Bern chooses Indica Labs’ HALO AP®

December 11, 2024

Categories: Corporate, Finance & Investor, Clinical Diagnostics

DevCo has completed a strategic capital raise for its long-term investment in Medix Biochemica

September 16, 2024

Categories: Corporate, Finance & Investor, Clinical Diagnostics, Pathology

Medical University of Graz selects the HALO AP® digital pathology platform to deliver comprehensive diagnostics

September 6, 2024

Categories: Clinical Diagnostics, Pathology

Indica Labs announces launch of AI-powered Macrodissection Suite to advance molecular pathology workflows

August 1, 2024

Categories: Healthcare, Corporate, Finance & Investor, Clinical Diagnostics

Surfix Diagnostics, the Netherlands Cancer Institute and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening

July 10, 2024

Categories: Corporate, Finance & Investor, Clinical Diagnostics

Medix Biochemica announces that Lonnie Shoff, former President of the Clinical Diagnostics Division at Thermo Fisher Scientific has been appointed its Board of Directors

July 8, 2024

Categories: Computing & Technology, Corporate, Finance & Investor, Clinical Diagnostics

Indica Labs expands availability of HALO digital pathology solutions in Asia Pacific Region including CE-IVDR marked HALO AP® platform

July 2, 2024

Categories: Microscopy & Imaging, Clinical Diagnostics

Indica Labs receives FDA clearance for HALO AP Dx digital pathology platform for use with Hamamatsu Images acquired with the NanoZoomer® S360MD Slide scanner

May 22, 2024

Categories: Biotechnology, Clinical Diagnostics

Indica Labs receives first FDA clearance for HALO AP Dx digital pathology platform

May 14, 2024